Cite

HARVARD Citation

    Saida, T. et al. (2017). Long-term efficacy and safety of fingolimod in Japanese patients with relapsing multiple sclerosis: 3-year results of the phase 2 extension study. BMC neurology. 17 (1), pp. 1-10. [Online]. 
  
Back to record